Milestone Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 14, 2023 at 02:41 pm EST
Share
Milestone Medical, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 0.764932 million compared to USD 0.9619 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.04 a year ago.
For the nine months, net loss was USD 2.5 million compared to USD 3.86 million a year ago. Basic loss per share from continuing operations was USD 0.11 compared to USD 0.18 a year ago.
Milestone Medical, Inc. develops epidural and intra-articular drug delivery systems based on patented, painless, computer-controlled injection and drug delivery technology. Its CompuFlo Epidural System provides anesthesiologists and other health care providers with the ability to determine and document the pressure at the needle tip in real-time. Its CompuFlo Epidural's DPS Dynamic Pressure Sensing Technology (DPS) allows the CompuFlo Epidural to provide objective visual and audible in-tissue pressure feedback that allows anesthesiologists to identify the epidural space. The DPS instrument is a patented computer-controlled injection system geared to the needs of the medical market. The Companyâs is also focused on marketing the Epidural medical and trainer instruments in the United States. The Companyâs products include medical instruments, handpieces/disposables, and other related products. It sells its products primarily through medical facilities and a global distribution network.